Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Eclipsys Announces Highlights for 2009 Annual User Conference

Tue. October 13, 2009; Posted: 08:30 AM
Stocks RSS
ATLANTA, Oct 13, 2009 (BUSINESS WIRE) -- ECLP | Quote | Chart | News | PowerRating -- Eclipsys Corporation(R) (NASDAQ:ECLP), The Outcomes Company(R), today announced upcoming highlights for its 2009 Eclipsys User Network (EUN) Outcomes Conference, October 14-17 in Dallas, TX. The EUN conference creates an annual forum of thousands of Eclipsys user representatives from world-renown healthcare systems, including 40 percent of "America's Best Hospitals," according to the U.S. News & World Report's 2009 ranking. The elite community of Eclipsys users also represents 45 percent of all organizations accepted into the Magnet Recognition Program(R), which recognizes health care organizations that provide nursing excellence.

New this year to EUN is an executive leadership agenda to provide details of Eclipsys' American Reinvestment and Recovery Act (ARRA) programs, including special available financing, the company's ARRA-HITECH warranty and a preview of the Sunrise Enterprise(TM) 5.5 solution, slated as Eclipsys' ARRA 2011 Certified EHR (electronic health record) Technology.

With more than 160 sessions scheduled over the course of four days, this year's EUN also will feature new Oncology, Pediatrics, and Academic specialty tracks, reflecting the fact that Eclipsys offers some of the most advanced computerized physician order entry (CPOE) functionality in the market, including support for complicated treatment plans commonplace in oncology and pediatric care environments. Eclipsys was cited in the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report (KLAS CPOE Digest 2009) issued by KLAS Enterprises, Inc. (KLAS), as having invested more time and effort in building an oncology extension into its clinical information system than other companies due to its physician adoption formula.

Other key highlights at the 2009 Eclipsys EUN Outcomes Conference include:

-- A company update from Eclipsys President and CEO, Phil Pead;

-- An overview of the freely available Eclipsys Outcomes Toolkits, which support Eclipsys client collaboration and sharing of best practices for care, including the company's HINI Toolkit developed in April 2009;

-- Physician practice sessions focused on the company's PeakPractice(TM) Ambulatory EHR solution.

Superiority in CPOE Positions Eclipsys Clients Well for ARRA "Meaningful Use" Requirements

"Eclipsys users are an elite group of healthcare providers that benefit from our company's 30 years of unmatched, continuous evolution in CPOE capabilities, and as such, we believe our clients perform at a higher level in terms of quality and outcomes," said Jay Deady, Eclipsys' executive vice president of Client Solutions. "In fact, based on publicly available data from the U.S. Department of Health and Human Services Hospital Compare site, Eclipsys clients rank No. 1 in composite performance across all Centers for Medicare and Medicaid Services Quality Measures. That data reinforces our client community's increased ability to affect positive patient outcomes and offer a safer clinical environment. As ARRA 'meaningful use' requirements are expected to become more advanced in 2013 and 2015, we believe our clinical solution's open architecture and highly complex clinical decision support capabilities will continue to bring even more value to Eclipsys clients and the patients they serve."

The Eclipsys EHR solution, Sunrise Clinical Manger(TM), has garnered widespread clinician adoption and has been recognized by KLAS as one of the industry's leading electronic records solutions. The system's capabilities are expected to advance a healthcare enterprise to "meaningful use" status in time to comply with ARRA requirements. Integrated with a comprehensive offering of enterprise applications, the solution maximizes electronic health record benefits by offering interoperable, fully connected care. According to the KLAS CPOE Digest 2009 report, Eclipsys CPOE solutions are used by more physicians in more hospitals than any other vendor systems. The company also continues to have the highest physician satisfaction from clients who use its system, and on average, highly customizable ordering capabilities allow a physician to order faster than any other CPOE solution on the market.

About the Magnet Recognition Program

The Magnet Recognition Program(R) was developed by the American Nurses Credentialing Center (ANNC) to recognize healthcare organizations that provide nursing excellence. The program also provides a vehicle for disseminating successful nursing practices and strategies. Recognizing quality patient care, nursing excellence and innovations in professional nursing practice, the Magnet Recognition Program provides consumers with the ultimate benchmark to measure the quality of care that they can expect to receive. For more information, go to www.nursingcredentialing.com.

About the KLAS CPOE Digest 2009

The KLAS CPOE Digest 2009 compiled data from healthcare executives, managers and clinicians. The study provided detailed information on several criteria including current CPOE usage at healthcare organizations, product capabilities and vendor performance.

About the Hospital Compare Web site

Hospital Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services, and other members of the Hospital Quality Alliance: Improving Care Through Information (HQA). The information on this website comes from hospitals that have agreed to submit quality information for Hospital Compare to make public. For more information, go to www.hospitalcompare.hhs.gov.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com , or email marketing@KLASresearch.com , or call 1-800-920-4109 to speak with a KLAS representative.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the timing of implementation and features of and benefits provided by Eclipsys software and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company's services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Enterprise, PeakPractice and Sunrise Clinical Manager are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.

SOURCE: Eclipsys Corporation

Eclipsys Corporation 
Robin Wrinn, 404-847-5219 
Director, Public Relations (media) 
robin.wrinn@eclipsys.com 
or 
Jason Cigarran, 404-847-5965 
Vice President, Investor Relations 
jason.cigarran@eclipsys.com
For full details on Eclipsys Corporation (ECLP) click here. Eclipsys Corporation (ECLP) has Short Term PowerRatings of 5. Details on Eclipsys Corporation (ECLP) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [ECLP]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.